Fibralign Corporation — Department of Defense SBIR Phase II: DHP14-009
Fibralign Corporation — SBIR Phase II award from Department of Defense.
- Amount
- $996,609
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase II
- Topic
- DHP14-009
- Solicitation
- 14.1
- NAICS
- —
- Place of performance
- CA
- Period
- 2019-02-07 → 2021-07-06
Description
To address the scarcity of effective treatments for volumetric muscle loss injuries, we propose a novel aligned multilumen nanofibrillar collagen scaffold loaded with Hepatocyte Growth Factor (HGF) modified messenger RNA (mmRNA) to direct functional muscl